1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Maraviroc (MVC): new trials by email Literature Review of Maraviroc (MVC) trials Research Report on Maraviroc (MVC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND) Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG) - HIV Infections | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 191 | 2016-04-21 | 2022-04-22 |
HIV Infections (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
Brazil (1) · Puerto Rico (1) · South Africa (1) · Thailand (1) · United States (1)